<bill session="117" type="h" number="5585" updated="2023-03-08T20:11:48Z">
  <state datetime="2022-06-22T18:44:52-04:00">PASS_OVER:HOUSE</state>
  <status>
    <unknown datetime="2022-06-22T18:44:52-04:00"/>
  </status>
  <introduced datetime="2021-10-15"/>
  <titles>
    <title type="display">ARPA&#226;&#8364;&#8220;H Act</title>
    <title type="short" as="introduced">Advanced Research Project Agency&#226;&#8364;&#8220;Health Act</title>
    <title type="short" as="introduced">ARPA&#226;&#8364;&#8220;H Act</title>
    <title type="short" as="reported to house">Advanced Research Projects Agency&#226;&#8364;&#8220;Health Act</title>
    <title type="short" as="reported to house">ARPA&#226;&#8364;&#8220;H Act</title>
    <title type="short" as="passed house">Advanced Research Projects Agency&#226;&#8364;&#8220;Health Act</title>
    <title type="short" as="passed house">ARPA&#226;&#8364;&#8220;H Act</title>
    <title type="official" as="introduced">To establish the Advanced Research Projects Agency-Health, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="E000215"/>
  <cosponsors>
    <cosponsor bioguide_id="A000371" joined="2021-11-30"/>
    <cosponsor bioguide_id="B001300" joined="2021-11-04"/>
    <cosponsor bioguide_id="B000490" joined="2022-04-07"/>
    <cosponsor bioguide_id="B001303" joined="2021-11-04"/>
    <cosponsor bioguide_id="B001313" joined="2022-06-08"/>
    <cosponsor bioguide_id="B001248" joined="2022-05-16"/>
    <cosponsor bioguide_id="C001112" joined="2022-03-31"/>
    <cosponsor bioguide_id="C001090" joined="2021-10-28"/>
    <cosponsor bioguide_id="C001066" joined="2022-01-28"/>
    <cosponsor bioguide_id="C001080" joined="2021-11-09"/>
    <cosponsor bioguide_id="C001067" joined="2022-02-15"/>
    <cosponsor bioguide_id="C001068" joined="2022-05-31"/>
    <cosponsor bioguide_id="C001059" joined="2021-10-28"/>
    <cosponsor bioguide_id="C001069" joined="2021-11-01"/>
    <cosponsor bioguide_id="C001119" joined="2021-11-01"/>
    <cosponsor bioguide_id="C001097" joined="2021-11-01"/>
    <cosponsor bioguide_id="D000197" joined="2022-02-04"/>
    <cosponsor bioguide_id="D000623" joined="2021-11-09"/>
    <cosponsor bioguide_id="D000624" joined="2022-01-25"/>
    <cosponsor bioguide_id="D000482" joined="2021-10-28"/>
    <cosponsor bioguide_id="F000466" joined="2022-04-07"/>
    <cosponsor bioguide_id="F000468" joined="2021-10-28"/>
    <cosponsor bioguide_id="G000551" joined="2022-03-01"/>
    <cosponsor bioguide_id="H001068" joined="2021-10-27"/>
    <cosponsor bioguide_id="J000305" joined="2021-12-14"/>
    <cosponsor bioguide_id="J000126" joined="2021-10-28"/>
    <cosponsor bioguide_id="K000385" joined="2022-01-25"/>
    <cosponsor bioguide_id="K000389" joined="2021-11-05"/>
    <cosponsor bioguide_id="K000382" joined="2022-01-20"/>
    <cosponsor bioguide_id="L000586" joined="2022-04-26"/>
    <cosponsor bioguide_id="L000593" joined="2021-11-04"/>
    <cosponsor bioguide_id="L000397" joined="2021-10-27"/>
    <cosponsor bioguide_id="M001163" joined="2022-01-25"/>
    <cosponsor bioguide_id="M001143" joined="2021-12-08"/>
    <cosponsor bioguide_id="M001200" joined="2022-03-15"/>
    <cosponsor bioguide_id="M000312" joined="2021-10-28"/>
    <cosponsor bioguide_id="M001166" joined="2021-11-02"/>
    <cosponsor bioguide_id="M001206" joined="2022-02-18"/>
    <cosponsor bioguide_id="M001196" joined="2022-01-03"/>
    <cosponsor bioguide_id="N000002" joined="2022-03-08"/>
    <cosponsor bioguide_id="N000179" joined="2021-11-04"/>
    <cosponsor bioguide_id="O000171" joined="2022-02-03"/>
    <cosponsor bioguide_id="P000096" joined="2021-11-01"/>
    <cosponsor bioguide_id="P000593" joined="2021-11-01"/>
    <cosponsor bioguide_id="P000608" joined="2021-11-04"/>
    <cosponsor bioguide_id="Q000023" joined="2022-01-03"/>
    <cosponsor bioguide_id="R000305" joined="2021-11-01"/>
    <cosponsor bioguide_id="R000486" joined="2021-10-27"/>
    <cosponsor bioguide_id="R000515" joined="2022-01-18"/>
    <cosponsor bioguide_id="S001168" joined="2022-02-15"/>
    <cosponsor bioguide_id="S001145" joined="2022-01-18"/>
    <cosponsor bioguide_id="S001150" joined="2021-11-15"/>
    <cosponsor bioguide_id="S001180" joined="2021-12-08"/>
    <cosponsor bioguide_id="S001216" joined="2021-11-04"/>
    <cosponsor bioguide_id="S001185" joined="2022-02-09"/>
    <cosponsor bioguide_id="S001200" joined="2022-03-17"/>
    <cosponsor bioguide_id="S001175" joined="2021-11-30"/>
    <cosponsor bioguide_id="S001201" joined="2021-10-28"/>
    <cosponsor bioguide_id="T000460" joined="2021-10-27"/>
    <cosponsor bioguide_id="T000469" joined="2021-11-04"/>
    <cosponsor bioguide_id="T000482" joined="2021-11-01"/>
    <cosponsor bioguide_id="T000483" joined="2021-11-30"/>
    <cosponsor bioguide_id="U000031" joined="2022-02-04"/>
    <cosponsor bioguide_id="W000797" joined="2021-10-28"/>
    <cosponsor bioguide_id="W000800" joined="2022-01-06"/>
    <cosponsor bioguide_id="W000788" joined="2022-06-08"/>
  </cosponsors>
  <actions>
    <action datetime="2021-10-15">
      <text>Introduced in House</text>
    </action>
    <action datetime="2021-10-15" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2021-10-18">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2022-05-11">
      <text>Subcommittee Consideration and Mark-up Session Held.</text>
    </action>
    <action datetime="2022-05-11">
      <text>Forwarded by Subcommittee to Full Committee by Voice Vote .</text>
    </action>
    <action datetime="2022-05-18">
      <text>Committee Consideration and Mark-up Session Held.</text>
    </action>
    <action datetime="2022-05-18" state="REPORTED">
      <text>Ordered to be Reported (Amended) by the Yeas and Nays: 53 - 3.</text>
    </action>
    <action datetime="2022-06-13">
      <text>Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-365.</text>
    </action>
    <calendar datetime="2022-06-13" calendar="Union" number="277">
      <text>Placed on the Union Calendar, Calendar No. 277.</text>
    </calendar>
    <action datetime="2022-06-21T17:28:41-04:00">
      <text>Rules Committee Resolution H. Res. 1191 Reported to House. Rule provides for consideration of H.R. 4176, H.R. 5585 and H.R. 7666. Rule provides for one hour of general debate on H.R. 4176, H.R. 5585 and H.R. 7666. Rule provides for one motion to recommit each for H.R. 4176, H.R. 5585 and H.R. 7666. Rule provides that proceedings may be postponed through July 15, 2022, on measures that were the object of motions to suspend the rules on the legislative days of June 21, 2022, June 22, 2022, June 23, 2022, or June 24, 2022, and on which the yeas and nays were ordered.</text>
    </action>
    <action datetime="2022-06-22T16:08:43-04:00">
      <text>Considered under the provisions of rule H. Res. 1191.</text>
      <reference ref="CR H5795-5803" label="consideration"/>
      <reference ref="CR H5795-5798" label="text"/>
    </action>
    <action datetime="2022-06-22T16:08:48-04:00">
      <text>Rule provides for consideration of H.R. 4176, H.R. 5585 and H.R. 7666. Rule provides for one hour of general debate on H.R. 4176, H.R. 5585 and H.R. 7666. Rule provides for one motion to recommit each for H.R. 4176, H.R. 5585 and H.R. 7666. Rule provides that proceedings may be postponed through July 15, 2022, on measures that were the object of motions to suspend the rules on the legislative days of June 21, 2022, June 22, 2022, June 23, 2022, or June 24, 2022, and on which the yeas and nays were ordered.</text>
    </action>
    <action datetime="2022-06-22T16:10:06-04:00">
      <text>DEBATE - The House proceeded with one hour of debate on H.R. 5585.</text>
    </action>
    <action datetime="2022-06-22T16:44:31-04:00">
      <text>DEBATE - Pursuant to the provisions of H. Res. 1170, the House proceeded with 10 minutes of debate on the Eshoo amendment No. 1.</text>
    </action>
    <action datetime="2022-06-22T16:47:44-04:00">
      <text>POSTPONED PROCEEDINGS - At the conclusion of debate on the Eshoo amendment, the Chair put the question on adoption of the amendment and by voice vote, announced that the ayes had prevailed. Mrs. Boebert demanded the yeas and nays and the Chair postponed further proceedings until a time to be announced.</text>
    </action>
    <action datetime="2022-06-22T16:48:19-04:00">
      <text>Pursuant to clause 1(c) of rule XIX, the Chair announced that further proceedings on H.R. 5585 would be postponed.</text>
    </action>
    <action datetime="2022-06-22T18:28:39-04:00">
      <text>Pursuant to clause 1(c) of rule XIX, the Chair announced that further proceedings on H.R. 5585 would resume.</text>
    </action>
    <action datetime="2022-06-22T18:28:40-04:00">
      <text>Considered as unfinished business.</text>
      <reference ref="CR H5808-5809" label="consideration"/>
    </action>
    <vote how="roll" type="vote" roll="288" datetime="2022-06-22T18:44:52-04:00" where="h" result="pass" state="PASS_OVER:HOUSE">
      <text>On passage Passed by the Yeas and Nays: 336 - 85 (Roll no. 288).</text>
    </vote>
    <action datetime="2022-06-22T18:44:54-04:00">
      <text>Motion to reconsider laid on the table Agreed to without objection.</text>
    </action>
    <action datetime="2022-06-23">
      <text>Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Referral"/>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Reporting, Markup, Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Reporting, Markup, Referral"/>
  </committees>
  <relatedbills>
    <bill session="117" type="hr" number="1191" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Advisory bodies"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Executive agency funding and structure"/>
    <term name="Federal officials"/>
    <term name="Government information and archives"/>
    <term name="Government studies and investigations"/>
    <term name="Health care costs and insurance"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Public contracts and procurement"/>
    <term name="Research administration and funding"/>
    <term name="Research and development"/>
    <term name="Technology transfer and commercialization"/>
  </subjects>
  <amendments>
    <amendment number="h238"/>
    <amendment number="h237"/>
  </amendments>
  <summary date="2022-06-28T16:23:57Z" status="Passed House">Advanced Research Projects Agency-Health Act or the ARPA-H Act

This bill establishes within the Department of Health and Human Services (HHS) the Advanced Research Projects Agency-Health to accelerate health and medical innovation by investing in high-risk, high-reward research. The bill also establishes a committee to advise on agency activities.

HHS must transfer all authorities, functions, funds, and personnel from a similar entity within the National Institutes of Health to a new, independent agency.

Additionally, the President must appoint a director to lead the agency. The director may submit testimony and recommendations concerning the agency to Congress without review or approval by other federal officers or agencies.

The director must appoint personnel to administer the agency's research programs, including by selecting projects to support and making recommendations about terminating or continuing projects.

The agency may use grants, prize competitions, and a variety of other mechanisms to support the research projects. The agency's budget is separate from that of HHS.

The agency must coordinate with the Food and Drug Administration and the Centers for Medicare &amp; Medicaid Services to expedite development and coverage of high-need cures. Additionally, the agency may partner with other public and private entities (e.g., institutions of higher education and patient advocacy organizations).

The bill also requires the agency to develop and periodically update a strategic plan and annually report on its activities. Furthermore, (1) the National Academies of Sciences, Engineering, and Medicine must evaluate the agency's performance; and (2) the Government Accountability Office must review the research portfolio of HHS and its components, including the new agency.</summary>
  <committee-reports>
    <report>H. Rept. 117-365</report>
  </committee-reports>
</bill>
